<DOC>
	<DOCNO>NCT02334163</DOCNO>
	<brief_summary>Evaluating efficacy safety nitazoxanide comparison standard treatment patient grade II-III hepatic encephalopathy ( HE ) . Also , Evaluating effect administer nitazoxanide improvement patient 's quality life .</brief_summary>
	<brief_title>The Effects Nitazoxanide Hepatic Encephalopathy</brief_title>
	<detailed_description>Nitazoxanide ( NTZ ) thiazolide anti-infective activity anaerobic bacteria , protozoa virus . A pilot prospective study 2008 American Association Study Liver Diseases meet show clinical improvement HE among cirrhotic patient receive nitazoxanide lactulose . Based excellent safety profile NTZ , present pilot study conduct hopefully prove efficacy nitazoxanide treat patient experience HE grade II-III . Study design : The study Prospective , Randomized , Controlled , Open-Label , Pilot study . Method : The study include total 36 patient grade II-III Hepatic Encephalopathy , inform consent obtain every patient include . All patient receive oral lactulose , plus either nitazoxanide , metronidazole rifaximine . A- All patient subject follow baseline : - Patient 's full history - Liver disease stag use Model End stage Liver Disease ( MELD ) score - Measurement serum electrolyte ( Na+ , K+ , Ca2+ ) B- All patient subject follow baseline end treatment : - Measuring Blood ammonia level - Measuring liver function test ( AST , Total bilirubin , international normalize ratio ( INR ) , Serum albumin , prothrombin time ( PT ) ) , serum creatinine complete blood count ( CBC ) - Assessing severity Hepatic Encephalopathy use Clinical Hepatic Encephalopathy Staging Scale ( CHESS ) C- Monitoring tolerability 30 day last dose D- Assessment quality life use Chronic Liver Disease Questionnaire ( CLDQ )</detailed_description>
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Hepatic Encephalopathy</mesh_term>
	<mesh_term>Lactulose</mesh_term>
	<mesh_term>Nitazoxanide</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>Adult Patients 18 65 year . Patients grade IIIII Hepatic Encephalopathy . Patients active GIT bleeding . Patients major psychiatric illness . Patients receive benzodiazepine , narcotic , alcohol marijuana . Patients compromise renal biliary function . Patients known AIDS . Patients receive medication highly bound plasma protein eg . Warfarin . Patients know hypersensitivity nitazoxanide . Pregnant lactating woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Hepatic Encephalopathy</keyword>
	<keyword>Nitazoxanide</keyword>
	<keyword>Serum ammonia</keyword>
</DOC>